[HTML][HTML] Cost-effectiveness of direct oral anticoagulant vs. warfarin among atrial fibrillation patients with intermediate stroke risk

JH Choi, W Kim, YT Kim, J Cho, SY Shin… - Frontiers in …, 2022 - frontiersin.org
Background Several studies have shown the cost-effectiveness of direct oral anticoagulants
(DOACs), compared with warfarin, to prevent atrial fibrillation (AF) related complications …

Clinical effects of off-label reduced doses of direct oral anticoagulants: a systematic review and meta-analysis

MQ Pereira, C David, AG Almeida, D Brito… - International Journal of …, 2022 - Elsevier
Abstract Backgound Atrial Fibrillation (AF) is the most prevalent cardiac arrhythmia among
older patients, associated with thromboembolic events. Direct Oral Anticoagulants (DOAC) …

New oral anticoagulants for stroke prevention in atrial fibrillation: impact of gender, heart failure, diabetes mellitus and paroxysmal atrial fibrillation

Y Ahmad, GYH Lip, S Apostolakis - Expert review of cardiovascular …, 2012 - Taylor & Francis
The emergence of new oral anticoagulants is a major development in cardiovascular
medicine. In this overview, we sought to evaluate the impact of gender, heart failure …

Effect of non‐recommended doses versus recommended doses of direct oral anticoagulants in atrial fibrillation patients: A meta‐analysis

X Liu, M Huang, C Ye, X Xiao, C Yan - Clinical Cardiology, 2021 - Wiley Online Library
Background Several observational studies have shown that the inappropriate dosing use of
direct oral anticoagulants (DOACs) in atrial fibrillation (AF) that does not conform to …

[HTML][HTML] Efficacy and safety of direct oral anticoagulants in elderly patients with atrial fibrillation: a network meta-analysis

K Deng, J Cheng, S Rao, H Xu, L Li, Y Gao - Frontiers in medicine, 2020 - frontiersin.org
Background: Direct oral anticoagulants (DOACs) have been widely used in patients with
atrial fibrillation (AF) for antithrombotic prophylaxis, which were shown to have a favorable …

[HTML][HTML] Clinical performance of oral anticoagulants in elderly with atrial fibrillation and low body weight: insight into Italian cohort of PREFER-AF and PREFER-AF …

V Russo, E Attena, M Baroni, R Trotta… - Journal of Clinical …, 2022 - mdpi.com
Background: Elderly patients are at high risk of both ischaemic and bleeding events, and the
low body weight is considered a risk factor for major bleeding in atrial fibrillation (AF) …

Oral anticoagulation across diabetic subtypes in patients with newly diagnosed atrial fibrillation: A report from the GARFIELD‐AF registry

JP Bassand, S Virdone, AJ Camm… - Diabetes, Obesity …, 2023 - Wiley Online Library
Aims This study aims to describe both management and prognosis of patients with diabetes
mellitus (DM) and newly diagnosed atrial fibrillation (AF), overall as well as by antidiabetic …